Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl) sulfonyl)-1H-indole scaffold as potent 5-HT6R antagonists: Design, synthesis, biological evaluation, and early in vivo cognition-enhancing studies

被引:3
作者
Yi, Chao [1 ]
Xue, Yaping [1 ]
Chen, Kangzhi [1 ]
Wang, Tao [1 ]
Yu, Jiahui [1 ]
Wang, Zusheng [1 ]
Jin, Chuanfei [1 ,2 ]
机构
[1] HEC Res & Dev Ctr, HEC Pharm Grp, Dongguan 523871, Peoples R China
[2] Sunshine Lake Pharm Co Ltd, Shenzhen 518000, Peoples R China
关键词
Alzheimer's disease; 5-HT(6 )antagonists; Idalopirdine; Difluoromethyl; ALZHEIMERS-DISEASE; RECEPTOR ANTAGONISTS; SEROTONIN; FLUORINE;
D O I
10.1016/j.bmc.2022.116917
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Herein, a series of novel 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole derivatives were designed and synthesized via hybridization strategy of idalopirdine and SB-271046. The optimal compound C14 (K-i = 0.085 nM), with difluoromethyl on C3 position on indole scaffold, increased the affinity for the 5-HT6R up to 10 -folds than idalopirdine (K-i = 0.83 nM). Additionally, C14 had good pharmacokinetic properties and in vitro metabolic properties. Finally, C14 could efficiently reverse the scopolamine induced emotional memory deficits in novel object recognition assay in rats. Thus, we propose C14 might be considered as a new cognition -enhancing agent and the further studies are now underway in our laboratory.
引用
收藏
页数:11
相关论文
共 28 条
[1]  
[Anonymous], 2018, The state of the art of dementia research: new frontiers
[2]   Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease [J].
Benhamu, Bellinda ;
Martin-Fontecha, Mar ;
Vazquez-Villa, Henar ;
Pardo, Leonardo ;
Lopez-Rodriguez, Maria L. .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (17) :7160-7181
[3]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205
[4]   Novel 3-(1,2,3,6-Tetrahydropyridin-4-yI)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity [J].
Bucki, Adam ;
Marcinkowska, Monika ;
Sniecikowska, Joanna ;
Wieckowski, Krzysztof ;
Pawlowski, Maciej ;
Gluch-Lutwin, Monika ;
Grybos, Anna ;
Siwek, Agata ;
Pytka, Karolina ;
Jastrzebska-Weisek, Magdalena ;
Partyka, Anna ;
Wesolowska, Anna ;
Mierzejewski, Pawel ;
Kolaczkowski, Marcin .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) :7483-7501
[5]   A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties [J].
Canale, Vittorio ;
Grychowska, Katarzyna ;
Kurczab, Rafal ;
Ryng, Mateusz ;
Keeri, Abdul Raheem ;
Satala, Grzegorz ;
Olejarz-Maciej, Agnieszka ;
Koczurkiewicz, Paulina ;
Drop, Marcin ;
Blicharz, Klaudia ;
Piska, Kamil ;
Pekala, Elzbieta ;
Janiszewska, Paulina ;
Krawczyk, Martyna ;
Walczak, Maria ;
Chaumont-Dubel, Severine ;
Bojarski, Andrzej J. ;
Marin, Philippe ;
Popik, Piotr ;
Zajdel, Pawel .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[6]   Serotonin: A New Hope in Alzheimer's Disease? [J].
Claeysen, Sylvie ;
Bockaert, Joel ;
Giannoni, Patrizia .
ACS CHEMICAL NEUROSCIENCE, 2015, 6 (07) :940-943
[7]   5-HT6 receptor and cognition [J].
Codony, Xabier ;
Miguel Vela, Jose ;
Javier Ramirez, Maria .
CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (01) :94-100
[8]   The current landscape in Alzheimer's disease research and drug discovery [J].
Devenish, Sean R. A. .
DRUG DISCOVERY TODAY, 2020, 25 (06) :943-945
[9]   Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status [J].
Ferrero, Hilda ;
Solas, Maite ;
Francis, Paul T. ;
Ramirez, Maria J. .
CNS DRUGS, 2017, 31 (01) :19-32
[10]   Applications of Fluorine in Medicinal Chemistry [J].
Gillis, Eric P. ;
Eastman, Kyle J. ;
Hill, Matthew D. ;
Donnelly, David J. ;
Meanwell, Nicholas A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) :8315-8359